Compass Rose Asset Management LP acquired a new position in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the fourth quarter, HoldingsChannel reports. The firm acquired 420,000 shares of the biopharmaceutical company’s stock, valued at approximately $21,550,000. Bristol-Myers Squibb comprises about 9.0% of Compass Rose Asset Management LP’s holdings, making the stock its 4th largest position. […]